Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/4/2009

September 14, 2009 to discuss the CRL and next steps. The meeting with the FDA provided clarification and alignment on a resubmission plan for us to fully address all deficiencies and issues identified in the CRL. Since the resubmission will include REMS materials, this is subject to a Class 2 review cycle, meaning a Prescription Drug User Fee Act date for all components of our filing six months after the date of our resubmission.
  • In September 2009, we committed to a corporate restructuring plan where we reduced our workforce by 25 employees. We expect that this cost savings initiative will save $2.9 million through the year ending December 31, 2010, net of $1.2 million of severance-related expenses.
  • In October 2009, we raised $65.7 million from an underwritten public offering of 4,945,000 shares of our common stock that yielded $60.9 million in cash, net of $4.8 million of offering costs.

The net loss for the third quarter of 2009 was $13.9 million, or $0.23 per basic and diluted share, on total revenues of $0.3 million, compared with a net loss of $18.2 million, or $0.34 per basic and diluted share, on total revenues of $0.5 million for the third quarter of 2008. Partially offsetting our net loss for the three months ended September 30, 2009 was non-cash gain of $11.8 million due to a valuation adjustment relating to warrants that we issued in connection with our April 2009 registered direct offering. On a non-Generally Accepted Accounting Principles (GAAP) basis and excluding the $11.8 million non-cash gain due to a valuation adjustment on our warrants, our net loss for the third quarter of 2009 was $25.7 million, or $0.42 per basic and diluted share, compared with a GAAP net loss for the third quarter of 2008 of $18.2 million, or $0.34 per basic and diluted share.

The net loss for the first nine months of 2009 was $90.6 million, or $1.56 per basic and diluted share, on tot
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... KV Pharmaceutical Company ( KVa/KVb) today announced that on ... (the "Notice") executed by the Marc S. Hermelin Revocable ... that the Board of Directors of the Company (the ... written consent relating to the proposed appointment of John ... Ronald J. Kanterman,s departure (the "Director Appointment"). ,, As ...
(Date:12/15/2009)... -- Dakim, Inc. and Alzheimer,s Weekly today announced the ... Health Contest, designed to help five seniors in their ... disease. All five winners will receive a $2,500 Dakim ... seniors preserve their brain health and the most widely ... across the country. ,, The contest, held ...
(Date:12/15/2009)... DURHAM, N.C., Dec. 15 A Harvard medical ... testosterone says that the PGA Tour,s decision last ... Barron,s doctor had diagnosed him as having the ... Barron for this condition is "unreasonable, unfair and ... of lower than normal testosterone levels, often referred ...
Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 75 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 2Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 3Harvard Medical Expert Criticizes PGA Tour, Calls Decision to Suspend Doug Barron for Doping 'Unreasonable, Unfair and Discriminatory' 4Award Winning Drug Awareness Campaign Enters Next Phase 57039 1Award Winning Drug Awareness Campaign Enters Next Phase 57039 2Award Winning Drug Awareness Campaign Enters Next Phase 57039 3Award Winning Drug Awareness Campaign Enters Next Phase 57039 4Lilly Names New Business Leaders 57034 1Lilly Names New Business Leaders 57034 2Lilly Names New Business Leaders 57034 3Lilly Names New Business Leaders 57034 4Lilly Names New Business Leaders 57034 5Lilly Names New Business Leaders 57034 6Lilly Names New Business Leaders 57034 7Lilly Names New Business Leaders 57034 8Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USA 14018 1Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USA 14018 2Fountain Healthy Aging Inc Announces Agreement to Acquire Natural Planet USA 14018 3
... CellCyte Genetics,Corporation (CellCyte) (OTC Bulletin Board: CCYG) ... University,s Feinberg,School of Medicine to perform an acute ... CellCyte,s CCG-TH30 product candidate. The goal,of the study ... CCG-TH30 therapy,in a disease model outcome study representative ...
... Approval Based on Updated Results Showing a 20% Reduction in ... 22% Improvement of Disease Free Survival at ... Colon Cancer, Post Surgery -, BRIDGEWATER, N.J., May 28 ... Administration (FDA) approved,the supplemental new drug application (sNDA) to include ...
Other Medicine Technology:CellCyte Genetics Signs Collaborative Agreement With Northwestern University's Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCyte's CCG-TH30 Product Candidate 2CellCyte Genetics Signs Collaborative Agreement With Northwestern University's Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCyte's CCG-TH30 Product Candidate 3CellCyte Genetics Signs Collaborative Agreement With Northwestern University's Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCyte's CCG-TH30 Product Candidate 4New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 2New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 3New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data 4
(Date:12/15/2009)... will train advocates to be leaders in the ... with support from experts in online learning, the ... Dec. 15 ONE and ... applications for the first-ever "Malaria Griots" program, a ... participants to become leaders in the fight against ...
(Date:12/15/2009)... 15 4R Systems, Inc., a leading ... which help retailers significantly increase profits by optimizing ... today that The Vitamin Shoppe has been utilizing ... store and DC inventory solutions have helped us ... in-stocks over the last two years," said Tony ...
(Date:12/15/2009)... WASHINGTON, Dec. 15 ... Republican Women Members of Congress that, "it doesn,t matter ... House bills - without a public option - give ... The bills also fund a new social agenda by ... inner city groups, newly arriving immigrants, and local politicians." ...
(Date:12/15/2009)... SALT LAKE CITY, Dec. 15 The new ... and Fitness ( www.LifeSpanFitness.com ), was highly ... the best treadmills for 2010. The compact TR200 folding ... Design, and Best Treadmill under $1000. ,, The ... walking indoors in small workout spaces. "This category buster ...
(Date:12/15/2009)... Lead to Indictment of 30 Individuals Charged in ... Million in Fraudulent Billing to Medicare ... have been charged in three cities for their ... $61 million in false Medicare claims as part ... Strike Force, Department of Health and Human Services ...
Breaking Medicine News(10 mins):Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5
... Inc.,(Nasdaq: OMCL ) a leading provider of system ... founder, chairman,president & CEO and Rob Seim, vice president & ... Conference at The New York Palace Hotel, New,York, NY. The ... on,Tuesday, December 2, 2008. , ...
... PITTSBURGH, Nov. 25 Astorino, an architecture,engineering, interior design ... applied innovative research techniques, never,before used on a VA ... The Veterans Recovery Center is located on Pittsburgh,s H. ... in a ribbon cutting ceremony,on Tuesday, November 25, 2008 ...
... BTE announces Massachusetts program enhancements to make it easier ... BOSTON, Nov. 25 For the fifth ... effort to measure and reward physicians for delivering high-quality ... Rewards paid to-date in the Commonwealth total more than ...
... cardiovascular events in men , , TUESDAY, Nov. 25 (HealthDay ... may pay the price, according to new research. , ... heart attack and death rose along with the reported ... first to provide evidence of a prospective, dose-response relationship ...
... The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: ... per common share, an increase of 4.5 cents per share or 15.8% ... 2009 to holders of record on December 12, 2008. At the current ... share. , , The Board has ...
... Nov. 25 Watson Pharmaceuticals,Inc. (NYSE: WPI ... agreement to acquire a portfolio of generic pharmaceutical,products that ... merger between,Teva Pharmaceutical Industries, Ltd. and Barr Pharmaceuticals, Inc. ... the consummation of,Teva,s merger with Barr. , ...
Other Medicine News:Health News:Omnicell to Present at Piper Jaffray 20th Annual Healthcare Conference 2Health News:Design Firm Taps Into Veterans' Subconscious to Aid in Designing First-of-its- Kind Recovery Center 2Health News:Doctors Receive Bonuses for Providing Optimal Care to Patients Through Bridges to Excellence 2Health News:Doctors Receive Bonuses for Providing Optimal Care to Patients Through Bridges to Excellence 3Health News:Bad Bosses Are Hard on the Heart 2Health News:Bad Bosses Are Hard on the Heart 3Health News:Bad Bosses Are Hard on the Heart 4Health News:BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases 2Health News:BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases 3Health News:Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr 2Health News:Watson Enters Into Agreement to Acquire Products Related to Teva's Proposed Acquisition of Barr 3
Insert only, Ethicon, small clip size...
Medium clip size, 10mm...
Ethicon, medium-large clip size, 10mm, rotatable take apart...
... appliers in 10mm and 5mm sizes. Our ... clip placement., ,The LIGACLIP ERCA Endoscopic ... single patient use instrument designed to provide ... Trocars. The instrument delivers 20 titanium clips ...
Medicine Products: